Along with nicotine reduction, the FDA plans to ease the path of entry for less-harmful nicotine delivery systems. The FDA “must also recognise potential for innovation to lead to less harmful products", Gottlieb said. Philip Morris has spent $3 billion on developing reduced-risk products. Representatives of Philip Morris and Altria did not respond to requests for comment. Reynolds American, a division of British American Tobacco, said it was encouraged by the move and that the FDA had recognised “tobacco harm-reduction policies and the continuum of risk for tobacco products".

Source: Bangkok Post July 29, 2017 12:00 UTC